Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Br J Ophthalmol ; 99(2): 251-4, 2015 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-25138767

RESUMO

PURPOSE: Toxic epidermal necrolysis (TEN) is a severe, life-threatening mucocutaneous disorder that frequently involves the ocular surface. This study aims to investigate the natural history and resolution of acute ocular involvement in patients with TEN admitted to the intensive care unit (ICU). METHODS: Case notes of patients admitted to ICU with TEN at a tertiary referral centre in a 9-year period were retrospectively reviewed. Patients' characteristics, severity of ocular involvement, SCORTEN systemic severity score and treatment were correlated with resolution of ocular involvement and time to resolution. RESULTS: Nine out of 10 (90%) patients had ocular involvement with 4 graded as mild, 2 as moderate and 3 as severe. All had bilateral ocular disease. The median length of hospital stay was 28 days and the median time to resolution of ocular involvement was 19 days. Four out of 9 (44%) patients still had active ocular disease at the time of discharge. Only older age (p=0.032) and a milder grade of ocular disease (p=0.001) were significantly associated with resolution of ocular disease. In a multivariable Cox-regression model, only a milder grade of ocular disease remained independently associated with time to resolution of ocular disease (p=0.006). CONCLUSIONS: Grading of acute ocular disease severity does not reflect systemic disease severity and is significantly associated with resolution and time to resolution of ocular involvement in TEN. The high rate of ocular involvement in patients with TEN and relatively large proportion of patients with active disease on discharge reiterates the need for constant ophthalmological monitoring of these patients.


Assuntos
Doenças da Túnica Conjuntiva/fisiopatologia , Doenças da Córnea/fisiopatologia , Doenças Palpebrais/fisiopatologia , Índice de Gravidade de Doença , Síndrome de Stevens-Johnson/fisiopatologia , Doença Aguda , Adulto , Idoso , Antibacterianos/administração & dosagem , Doenças da Túnica Conjuntiva/classificação , Doenças da Túnica Conjuntiva/tratamento farmacológico , Doenças da Córnea/classificação , Doenças da Córnea/tratamento farmacológico , Doenças Palpebrais/classificação , Doenças Palpebrais/tratamento farmacológico , Feminino , Glucocorticoides/administração & dosagem , Humanos , Imunoglobulinas Intravenosas/administração & dosagem , Imunossupressores/administração & dosagem , Unidades de Terapia Intensiva , Tempo de Internação , Lubrificantes/administração & dosagem , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Síndrome de Stevens-Johnson/classificação , Síndrome de Stevens-Johnson/tratamento farmacológico , Adulto Jovem
3.
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA